期刊文献+

mdr-1表达与食管癌相关病理因素的研究 被引量:1

THE RELATIONSHIP BETWEEN THE EXPERSSION OF MDR 1 GENE AND PATHOLOGICAL FACTORS IN ESOPHAGEAL CARCINOMA
原文传递
导出
摘要 目的 :探讨食管癌组织中多药耐药基因 (mdr- 1)表达与相关病理因素的关系。方法 :应用反转录聚合酶链反应 (RT- PCR)方法 ,对 78例食管癌及癌旁组织中 m dr- 1表达进行检测。结果 :78例食管癌中 mdr- 1阳性32例 (4 1% ) ,癌旁组织 m dr- 1阳性率 8例 (10 % ) ,癌组织的 mdr- 1阴性与癌旁组织比较具有显著性差异 (P<0 .0 0 1)。m dr- 1表达阳性与肿瘤大小、浸润深度、病理分期及淋巴结转移与否无明显关系 ,但在肿瘤侵犯深肌层或纤维层时的 m dr- 1表达阳性率 (4 5 .8% )明显高于侵犯浅肌层或粘膜层者 (2 6 .3 % ) ,低分化食管癌的 mdr- 1阳性分布显著高于高中分化肿瘤 (P<0 .0 5 )。对术后 1年以上的 42例患者随访发现 ,mdr- 1阳性的肿瘤复发、转移发生率也高于 mdr- 1表达阴性者。结论 :食管癌组织中 m dr- 1基因表达增高 ,mdr- 1的阳性表达不仅表现肿瘤的多药耐药性 ,还可能提示肿瘤的分化不良 。 Objective:To evaluate the expression of mdr 1 gene and its relation with pathological fators of esophageal cancer.Methods:A series of 78 resected tumor tissues from esophageal cancer patients and adjacent normal esophagus tissues were analyzed for mdr 1 gene experssion by RT PCR method.Rusults:The mdr 1 positive rate differed significantly between cancer tissue (41 %) and paracancerous tissue (10 %, P <0.01).Positive expression of mdr 1 gene was not associated with tumor size,infiltration depth,TNM stages and lymphnode metastasis ( P >0.05),but in deep muscularis or fibro membrane invaded by tumor,the mdr 1 positive rates (45.8%) were higher in comparison with invasion shallow muscularis or mucous membrance (26.3 %).The mdr 1 gene expression in undifferentiated tumor was significantly higher than that in well defferentiated ones( P <0.05).The relapse or metastasis rates with mdr 1 positive cases was still higher (44.4 %) than that with mdr 1 negative (29.9 %) by follow up of these patients.Conclusion:In esophageal cancer tissues,positive expression of mdr 1 gene may indicate undifferentiated tumor and be regarded as a poorly prognositic marker.
机构地区 解放军第
出处 《肿瘤研究与临床》 CAS 2001年第2期98-99,共2页 Cancer Research and Clinic
关键词 mdr-1表达 病理因素 食管癌 Esophageal cancer mdr -1 gene expression Pathological factors
  • 相关文献

参考文献1

二级参考文献1

  • 1Kruh G D,Cancer Res,1994年,54期,1649页

共引文献4

同被引文献4

  • 1[2]Elledge RM, Green S, Pugh R, et al. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER,PgR and PS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer. Int J Cancer, 2000,89(2):111~7.
  • 2[3]Nikolic-Vukosavljevic D, Grujic-Adanja G, Jankovic R, et al. PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression. Neoplasma, 2001,48(1):1~6.
  • 3[5]Hery JA, Bennett MK, Piggott NH, et al. Expression of the PNR2/PS2 protein in diverse human epithelial tumors. Br J Cancer,1991,64(4):677~82.
  • 4丁秀敏,何振祥,张文萍,方志沂,赵颖.雌激素调节蛋白PS2在乳腺癌组织中的表达及其应用[J].实用肿瘤杂志,2001,16(4):235-237. 被引量:8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部